Skip to main content
. 2021 Dec 8;16(12):e0260259. doi: 10.1371/journal.pone.0260259

Table 2. Persistence days of post-recovery of COVD-19 recorded symptoms in 979 studied subjects.

Descriptive Statistics Mean (days) Median (days) Standard Deviation Range (days) No. % p-value
I-General Symptoms Fatigue Days 7 5 8.6 120 719 73% 0.004*
Weakness Days 8.1 5 9.8 119 715 73% 0.001*
II- Skin and Musculoskeletal symptoms Muscle aches Days 7.8 5 12 119 646 66% 0.14
Joint pains Days 7.2 5 9.4 119 595 61% 0.01*
Skin Rash Days 5.4 2 11.7 119 164 17% 0.62
III- Psychological and Neurological symptoms Headache Days 6.5 4 8.2 119 627 64% 0.73
Mood changes Days 9.5 7 11.9 154 501 51% 0.03*
Insomnia Days 8.8 7 10.6 89 432 44% 0.21
Paraesthesia and anesthesia Days 7 4 11.1 119 296 30% 0.85
IV- Special sense symptoms Hearing problems Days 7.5 5 11.9 119 129 13% 0.94
Visual disturbances Days 7.3 4 9.9 59 145 15% 0.40
Dry eyes Days 7.9 5 11 63 185 19% 0.88
Loss of smell Days 15.9 10 19.5 149 604 62% 0.63
Loss of taste Days 13.9 9 16.6 119 555 57% 0.60
V- Respiratory system symptoms Cough Days 11 7 12.8 120 457 47% 0.09
Breathlessness and chest tightness Days 9 6 10.7 119 388 40% 0.45
VI- Gastrointestinal symptoms Lack of appetite Days 9.4 7 8 59 455 46% 0.003*
Nausea Days 6.9 5 7 59 313 32% 0.002*
Diarrhea Days 6.4 4 8.8 119 402 41% 0.42
Abdominal pain Days 6 4 6.6 44 253 26% 0.02*

*p<0.05 considered statistically significant. P values were calculated by ANOVA and LSD tests using SPSS software.

The mean (±SD) age of the subjects was 37.69 (±10.767) years.